Anti-IRF3 (phospho S386) antibody [EPR2346]

Name Anti-IRF3 (phospho S386) antibody [EPR2346]
Supplier Abcam
Catalog ab76493
Prices $387.00
Sizes 100 µl
Host Rabbit
Clonality Monoclonal
Isotype IgG
Clone EPR2346
Applications WB ICC/IF ICC/IF
Species Reactivities Human
Antigen Phospho-specific peptide corresponding to residues surrounding Serine 386 of Human IRF3
Description Rabbit Monoclonal
Gene IRF3
Conjugate Unconjugated
Supplier Page Shop

Product images


Product References

Dengue virus subverts the interferon induction pathway via NS2B/3 - Dengue virus subverts the interferon induction pathway via NS2B/3

Anglero-Rodriguez YI, Pantoja P, Sariol CA. Clin Vaccine Immunol. 2014 Jan;21(1):29-38.

TRIM14 is a mitochondrial adaptor that facilitates retinoic acid-inducible - TRIM14 is a mitochondrial adaptor that facilitates retinoic acid-inducible

Zhou Z, Jia X, Xue Q, Dou Z, Ma Y, Zhao Z, Jiang Z, He B, Jin Q, Wang J. Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):E245-54. doi:

Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures - Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures

Santiago FW, Covaleda LM, Sanchez-Aparicio MT, Silvas JA, Diaz-Vizarreta AC, Patel JR, Popov V, Yu XJ, Garcia-Sastre A, Aguilar PV. J Virol. 2014 Apr;88(8):4572-85.

TLR3 activation augments matrix metalloproteinase production through reactive - TLR3 activation augments matrix metalloproteinase production through reactive

Ichikawa T, Sugiura H, Koarai A, Minakata Y, Kikuchi T, Morishita Y, Oka A, Kanai K, Kawabata H, Hiramatsu M, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Yamamoto N, Ichinose M. J Immunol. 2014 Jun 1;192(11):4977-88.

Enterovirus 68 3C protease cleaves TRIF to attenuate antiviral responses mediated - Enterovirus 68 3C protease cleaves TRIF to attenuate antiviral responses mediated

Xiang Z, Li L, Lei X, Zhou H, Zhou Z, He B, Wang J. J Virol. 2014 Jun;88(12):6650-9.

Evaluating TBK1 as a therapeutic target in cancers with activated IRF3. - Evaluating TBK1 as a therapeutic target in cancers with activated IRF3.

Muvaffak A, Pan Q, Yan H, Fernandez R, Lim J, Dolinski B, Nguyen TT, Strack P, Wu S, Chung R, Zhang W, Hulton C, Ripley S, Hirsch H, Nagashima K, Wong KK, Janne PA, Seidel-Dugan C, Zawel L, Kirschmeier PT, Middleton RE, Morris EJ, Wang Y. Mol Cancer Res. 2014 Jul;12(7):1055-66.

RIOK3 is an adaptor protein required for IRF3-mediated antiviral type I - RIOK3 is an adaptor protein required for IRF3-mediated antiviral type I

Feng J, De Jesus PD, Su V, Han S, Gong D, Wu NC, Tian Y, Li X, Wu TT, Chanda SK, Sun R. J Virol. 2014 Jul;88(14):7987-97.

Toll-like receptor-3 is dispensable for the innate microRNA response to West Nile - Toll-like receptor-3 is dispensable for the innate microRNA response to West Nile

Chugh PE, Damania BA, Dittmer DP. PLoS One. 2014 Aug 15;9(8):e104770.

HSCARG negatively regulates the cellular antiviral RIG-I like receptor signaling - HSCARG negatively regulates the cellular antiviral RIG-I like receptor signaling

Peng Y, Xu R, Zheng X. PLoS Pathog. 2014 Apr 24;10(4):e1004041.

RING finger protein 11 targets TBK1/IKKi kinases to inhibit antiviral signaling. - RING finger protein 11 targets TBK1/IKKi kinases to inhibit antiviral signaling.

Charoenthongtrakul S, Gao L, Parvatiyar K, Lee D, Harhaj EW. PLoS One. 2013;8(1):e53717.